Anúncio
Anúncio

TDOC

TDOC logo

Teladoc Health, Inc.

7.46
USD
Patrocinado
-0.16
-2.05%
09 de jan., 15:59 UTC -5
Encerrado
exchange

Pré-Mercado

7.41

-0.05
-0.74%

Relatórios de Lucros TDOC

Rácio de surpresa positiva

TDOC separação 24 de 40 últimas estimativas.

60%

Próximo Relatório

Data do Próximo Relatório
24 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$647.68M
/
-$0.19
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+3.39%
/
-32.14%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+1.12%
/
-32.14%

Teladoc Health, Inc. earnings per share and revenue

On 29 de out. de 2025, TDOC reported earnings of -0.28 USD per share (EPS) for Q3 25, missing the estimate of -0.27 USD, resulting in a -3.17% surprise. Revenue reached 626.44 milhão, compared to an expected 638.43 milhão, with a -1.88% difference. The market reacted with a +6.20% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 28 analistas forecast an EPS of -0.19 USD, with revenue projected to reach 647.68 milhão USD, implying an diminuir of -32.14% EPS, and aumentar of 3.39% in Revenue from the last quarter.
FAQ
For Q3 2025, Teladoc Health, Inc. reported EPS of -$0.28, missing estimates by -3.17%, and revenue of $626.44M, -1.88% below expectations.
The stock price moved up 6.2%, changed from $8.23 before the earnings release to $8.74 the day after.
The next earning report is scheduled for 24 de fev. de 2026.
Based on 28 analistas, Teladoc Health, Inc. is expected to report EPS of -$0.19 and revenue of $647.68M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio